These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 8969737)

  • 21. Comparative evaluation of NBUVB phototherapy and PUVA photochemotherapy in chronic plaque psoriasis.
    Dayal S; ; Jain VK
    Indian J Dermatol Venereol Leprol; 2010; 76(5):533-7. PubMed ID: 20826993
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Photochemotherapy--psoralen + UV-A (PUVA)--increased risk of cancer?].
    Harnes DK; Thune P
    Tidsskr Nor Laegeforen; 1993 Jan; 113(2):200-1. PubMed ID: 8430401
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Toxic hepatitis from oral methoxsalen photochemotherapy (PUVA).
    Pariser DM; Wyles RJ
    J Am Acad Dermatol; 1980 Sep; 3(3):248-50. PubMed ID: 7451691
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cutaneous squamous-cell carcinoma in patients treated with PUVA.
    Stern RS; Laird N; Melski J; Parrish JA; Fitzpatrick TB; Bleich HL
    N Engl J Med; 1984 May; 310(18):1156-61. PubMed ID: 6709010
    [TBL] [Abstract][Full Text] [Related]  

  • 25. p53 immunoreactivity in cutaneous PUVA tumors is similar to that in other non-melanoma skin neoplasms.
    Proby CM; du Peloux Menagé H; McGregor JM; Hobbs C; Norris PG; Smith N; Hawk JL; McKee PH
    J Cutan Pathol; 1993 Oct; 20(5):435-41. PubMed ID: 8300928
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carcinogenic risks of psoralen UV-A therapy and narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review.
    Archier E; Devaux S; Castela E; Gallini A; Aubin F; Le Maître M; Aractingi S; Bachelez H; Cribier B; Joly P; Jullien D; Misery L; Paul C; Ortonne JP; Richard MA
    J Eur Acad Dermatol Venereol; 2012 May; 26 Suppl 3():22-31. PubMed ID: 22512677
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non-melanoma skin cancer occurring in patients treated with PUVA five to ten years after first treatment.
    Stern RS; Lange R
    J Invest Dermatol; 1988 Aug; 91(2):120-4. PubMed ID: 3397587
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The risk of squamous cell and basal cell cancer associated with psoralen and ultraviolet A therapy: a 30-year prospective study.
    Stern RS;
    J Am Acad Dermatol; 2012 Apr; 66(4):553-62. PubMed ID: 22264671
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carcinogenic risk of bath PUVA in comparison to oral PUVA therapy.
    Shephard SE; Panizzon RG
    Dermatology; 1999; 199(2):106-12. PubMed ID: 10559574
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Photocarcinogenesis].
    Amblard P; Béani JC; Reymond JL; Didier-Roberto B
    Ann Dermatol Venereol; 1987; 114(3):381-94. PubMed ID: 3300507
    [No Abstract]   [Full Text] [Related]  

  • 31. Cutaneous malignancies in patients treated with psoralen photochemotherapy (PUVA) for vitiligo.
    Halder RM; Battle EF; Smith EM
    Arch Dermatol; 1995 Jun; 131(6):734-5. PubMed ID: 7778934
    [No Abstract]   [Full Text] [Related]  

  • 32. Lenticular psoralen photoproducts and cataracts of a PUVA-treated psoriatic patient.
    Woo TY; Wong RC; Wong JM; Anderson TF; Lerman S
    Arch Dermatol; 1985 Oct; 121(10):1307-8. PubMed ID: 4037825
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risks and benefits of the treatment of psoriasis.
    Epstein JH
    N Engl J Med; 1979 Apr; 300(15):852-3. PubMed ID: 423922
    [No Abstract]   [Full Text] [Related]  

  • 34. Combination therapy for psoriasis with methotrexate and etretinate.
    Tuyp E; MacKie RM
    J Am Acad Dermatol; 1986 Jan; 14(1):70-3. PubMed ID: 3950115
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Malignant melanoma in a patient with severe psoriasis treated by oral methoxsalen photochemotherapy.
    Frenk E
    Dermatologica; 1983; 167(3):152-4. PubMed ID: 6414855
    [No Abstract]   [Full Text] [Related]  

  • 36. British Photodermatology Group guidelines for PUVA.
    Br J Dermatol; 1994 Feb; 130(2):246-55. PubMed ID: 8123580
    [No Abstract]   [Full Text] [Related]  

  • 37. Outcomes of pregnancies among women and partners of men with a history of exposure to methoxsalen photochemotherapy (PUVA) for the treatment of psoriasis.
    Stern RS; Lange R
    Arch Dermatol; 1991 Mar; 127(3):347-50. PubMed ID: 1998364
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutagenicity and carcinogenicity of methoxsalen plus UV-A.
    Roelandts R
    Arch Dermatol; 1984 May; 120(5):662-9. PubMed ID: 6372701
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term follow-up of skin cancer in the PUVA-48 cooperative study.
    Forman AB; Roenigk HH; Caro WA; Magid ML
    Arch Dermatol; 1989 Apr; 125(4):515-9. PubMed ID: 2649011
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The relationship of skin cancer to PUVA therapy in Australia.
    Lobel E; Paver K; King R; Le Guay J; Poyzer K; Wargon O
    Australas J Dermatol; 1981 Dec; 22(3):100-3. PubMed ID: 7344686
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.